You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunomodulatory Drugs (IMiDs)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Safety and Efficacy Trial in Suzhou (anti-CD19 and anti-BCMA CAR, Immunomodulatory drugs)

Recruiting
  • Safety and Efficacy
  • anti-CD19 and anti-BCMA CAR
  • Immunomodulatory drugs
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
May 17, 2021

Physiological Effects of Drugs Trial in Rio De Janeiro (Dexmedetomidine Hydrochloride)

Recruiting
  • Physiological Effects of Drugs
  • Dexmedetomidine Hydrochloride
  • Rio De Janeiro, Brazil
    University Hospital Gaffree and Guinle
Aug 3, 2022

Immune-related Adverse Events Refractory to Standard Therapy and

Recruiting
  • Immune-related Adverse Event
  • Extracorporeal photopheresis
  • Other immunosuppressive or immunomodulatory drugs
  • Munich, Germany
    LMU Klinikum Hauttumorzentrum
Jan 17, 2023

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Bone Marrow Biopsy
  • +3 more
  • Phoenix, Arizona
  • +2 more
Jan 18, 2023

Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston

Active, not recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 26, 2022

Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • ISB 2001
  • Benowa, Queensland, Australia
    Pindara Private Hospital
May 18, 2023

IBD Trial (Pfizer Comirnaty vaccine)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Pfizer Comirnaty vaccine
  • (no location specified)
Feb 23, 2021

Incident IMID in Patients Treated With Biologics and

Not yet recruiting
  • Inflammatory Disease
    • Paris, France
      Hôpital Saint-Antoine
    Jan 23, 2023

    Venous Thromboembolism Trial in Valencia (Apixaban 2.5 MG)

    Terminated
    • Venous Thromboembolism
    • Apixaban 2.5 MG
    • Valencia, Spain
    • +3 more
    Feb 12, 2021

    High Grade Squamous Intra-epithelial Lesion (HSIL) Trial in Darlinghurst (Pomalidomide 2 MG Oral Capsule [Pomalyst])

    Active, not recruiting
    • High Grade Squamous Intra-epithelial Lesion (HSIL)
    • Pomalidomide 2 MG Oral Capsule [Pomalyst]
    • Darlinghurst, New South Wales, Australia
      St Vincent's Hospital
    Mar 28, 2022

    Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)

    Not yet recruiting
    • Relapsed and Refractory Multiple Myeloma
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Sep 15, 2023

    Thrombosis in Multiple Myeloma in an University Medical Center

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Multiple myeloma
    • Groningen, Netherlands
      University Medical Center Groningen
    Sep 12, 2022

    MDS Trial in Beijing (Lenalidomide, Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Multiple Myeloma Trial in Durham (Opaganib)

    Terminated
    Has Results
    • Multiple Myeloma
    • Durham, North Carolina
      Duke University Medical Center
    May 24, 2021

    Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

    Recruiting
    • Cutaneous T-Cell Lymphoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Rheumatic Diseases Trial in Ciudad Autónoma de Buenos Aires (Immunosuppressive Agents)

    Completed
    • Rheumatic Diseases
    • Immunosuppressive Agents
    • Ciudad Autónoma de Buenos Aires, Caba, Argentina
      Sociedad Argentina de Reumatología
    Jan 30, 2023

    Serum NGAL IN Patients With Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma(MM)
    • SERUM NGAL
    • (no location specified)
    Jun 26, 2022

    CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)

    Recruiting
    • CNS Lymphoma
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Aug 10, 2022

    Multiple Myeloma Trial in New Haven (Elotuzumab, Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • New Haven, Connecticut
      Yale New Haven Hospital
    Aug 15, 2022

    Chronic Heart Failure Patients Trial (Eprolidone)

    Not yet recruiting
    • Chronic Heart Failure Patients
    • (no location specified)
    Jun 28, 2023

    Refractory Multiple Myeloma Trial in Switzerland (Pomalidomide, Dexamethasone)

    Terminated
    • Refractory Multiple Myeloma
    • Aarau, Switzerland
    • +15 more
    Jun 7, 2021

    Multiple Myeloma Trial in Beijing (Ixazomib, Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Beijing, Beijing, China
      PekingUMCH
    Nov 30, 2021

    Investigate eNAMPT in Multiple Myeloma Biology and Establish Its

    Recruiting
    • Multiple Myeloma
      • Torino, TO, Italy
        Aou Citta' Della Salute E Della Scienza Di Torino
      Aug 17, 2021

      Rheumatic Diseases Trial in Portland (Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine)

      Recruiting
      • Rheumatic Diseases
      • Hepatitis A vaccine
      • Diphtheria, pertussis, and tetanus booster vaccine
      • Portland, Oregon
        Oregon Health & Science University
      Sep 14, 2022

      Hematologic Tumors, Multiple Myeloma, Efficacy Trial in Jin'an (RDD, VDD)

      Recruiting
      • Hematologic Neoplasms
      • +3 more
      • Jin'an, Shandong, China
        Department of Hematology, Provincial Hospital Affiliated to Shan
      Nov 26, 2019